MARKET

CFMS

CFMS

ConforMIS
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.8385
+0.0234
+2.87%
Opening 15:23 05/07 EDT
OPEN
0.8000
PREV CLOSE
0.8151
HIGH
0.8463
LOW
0.8000
VOLUME
554.42K
TURNOVER
--
52 WEEK HIGH
1.490
52 WEEK LOW
0.6015
MARKET CAP
152.97M
P/E (TTM)
-2.8785
1D
5D
1M
3M
1Y
5Y
ConforMIS (CFMS) Receives a Buy from Oppenheimer
Oppenheimer analyst Steven Lichtman maintained a Buy rating on ConforMIS (CFMS) today and set a price target of $3.00. The company's shares closed last
SmarterAnalyst · 1d ago
ConforMIS (CFMS) Reports Q1 Loss, Misses Revenue Estimates
ConforMIS (CFMS) delivered earnings and revenue surprises of -12.50% and -0.29%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 1d ago
BRIEF-Conformis Posts Q1 Loss Per Share $0.09
reuters.com · 1d ago
10-Q: CONFORMIS INC
(EDGAR Online via COMTEX) -- ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS The following discussion and...
Edgar Online - (EDG = 10Q, 10K) · 1d ago
Conformis: Q1 Earnings Insights
Shares of Conformis (NASDAQ:CFMS) fell in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 35.71% year over year to ($0.09), which missed the estimate of ($0.07).
Benzinga · 1d ago
Conformis Q1 EPS $(0.09) Misses $(0.07) Estimate, Sales $13.84M Beat $13.77M Estimate
Conformis (NASDAQ:CFMS) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.07) by 28.57 percent. This is a 35.71 percent increase over losses of $(0.14) per share from the
Benzinga · 1d ago
ConforMIS EPS misses by $0.02, beats on revenue
ConforMIS (CFMS): Q1 GAAP EPS of -$0.09 misses by $0.02.Revenue of $13.84M (-16.0% Y/Y) beats by $0.06M.Press Release
Seekingalpha · 1d ago
Conformis Reports First Quarter 2021 Financial Results
BILLERICA, Mass., May 05, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial results for the first quarter ended March 31, 202...
GlobeNewswire · 1d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CFMS. Analyze the recent business situations of ConforMIS through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CFMS stock price target is 2.333 with a high estimate of 3.000 and a low estimate of 2.000.
EPS
Institutional Holdings
Institutions: 116
Institutional Holdings: 19.66M
% Owned: 10.78%
Shares Outstanding: 182.43M
TypeInstitutionsShares
Increased
13
1.23M
New
6
299.13K
Decreased
11
874.81K
Sold Out
7
7.71M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.67%
Healthcare Equipment & Supplies
+0.88%
Key Executives
Chairman/Independent Director
Kenneth Fallon
President/Chief Executive Officer/Director
Mark Augusti
Chief Financial Officer/Treasurer
Robert Howe
Senior Vice President
Gary Maingot
Secretary
J. Brent Alldredge
Director
Carrie Bienkowski
Independent Director
Philip Johnston
Independent Director
Bradley Langdale
Independent Director
Richard Meelia
Independent Director
Michael Milligan
No Data
About CFMS
ConforMIS, Inc. is a medical technology company. The Company uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants, which are individually sized and shaped, to fit each patient's anatomy. The Company's iFit technology platform is applicable to various joints. It offers a line of customized knee implants designed to restore the natural shape of a patient's knee. It offers iTotal CR, which is a total knee replacement implant. Its iFit technology platform consists of three elements, including iFit Design, its algorithms and computer software that is used to design customized implants and associated single-use patient-specific instrumentation referred to as iJigs, based on computed tomography scans of the patient and to prepare a surgical plan customized for the patient (iView); iFit Printing, which is a three-dimensional printing technology used to manufacture iJigs, and iFit Just-in-Time manufacturing and delivery capabilities.

Webull offers kinds of ConforMIS Inc stock information, including NASDAQ:CFMS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CFMS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CFMS stock methods without spending real money on the virtual paper trading platform.